On March 14, 2022, Raymond Pratt notified Rockwell Medical, Inc. of his decision to resign as the Company's Chief Development Officer, effective as of March 25, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 USD | +1.17% | +6.06% | -7.41% |
May. 14 | Transcript : Rockwell Medical, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (RMTI) ROCKWELL MEDICAL Reports Q1 Revenue $22.7M, vs. Street Est of $21.7M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.41% | 50.21M | |
+33.20% | 709B | |
+30.77% | 595B | |
-2.29% | 367B | |
+20.20% | 334B | |
+4.88% | 289B | |
+14.32% | 239B | |
+9.07% | 211B | |
-3.44% | 203B | |
+8.47% | 171B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Raymond Pratt Resigns from Rockwell Medical, Inc. as Chief Development Officer, Effective March 25, 2022